FDA urged to preserve antibacterial products, ingredients

American Cleaning Institute is asking the Food and Drug Administration to re-evaluate antibacterial data


The Food and Drug Administration (FDA) is being urged to re-evaluate data relevant to the safety and efficacy of antibacterial healthcare ingredients, according to an article on the Infection Control Today website.

The American Cleaning Institute (ACI) is asking the FDA to make affirmative findings that they are generally recognized as safe and effective.

“The active ingredients used in healthcare antiseptic drug products have very favorable benefit/risk ratios demonstrated over many years of extensive use,” according to Dr. Paul DeLeo, ACI associate vice president of environmental safety. 

ACI also asked the FDA not to change safety classifications of several key antibacterial ingredients

Read the article.

 

 



November 10, 2015


Topic Area: Industry News


Recent Posts

Dirty Floors: How Pathogens Can Accumulate and Spread Underfoot

Studies show that healthcare floors are covered in bacteria and can quickly spread throughout patient rooms. 


WellSpan Health Opens Its Newberry Hospital in Pennsylvania


Cahaba Center for Mental Health Ensnared in Data Breach

On March 28, 2025, Cahaba identified suspicious activity in an employee email account.


Reframing the Construction Manager as a Community Manager

Managers must work with patients, community residents and other interested parties to ensure a smooth, successful construction projects


Health First Celebrates 'Topping Off' Ceremony for New Cape Canaveral Hospital Campus

Construction is slated to finish by the end of 2026 or early 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.